Fenne L. Komdeur

974 total citations
11 papers, 562 citations indexed

About

Fenne L. Komdeur is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Fenne L. Komdeur has authored 11 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Immunology and 3 papers in Genetics. Recurrent topics in Fenne L. Komdeur's work include Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (5 papers) and Immune Cell Function and Interaction (4 papers). Fenne L. Komdeur is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (5 papers) and Immune Cell Function and Interaction (4 papers). Fenne L. Komdeur collaborates with scholars based in Netherlands, United States and United Kingdom. Fenne L. Komdeur's co-authors include Annechien Plat, Hans W. Nijman, Marco de Bruyn, Harry Hollema, G. Bea A. Wisman, Maartje C.A. Wouters, Hagma H. Workel, David N. Church, Thalina M. Prins and Florine A. Eggink and has published in prestigious journals such as SHILAP Revista de lepidopterología, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

In The Last Decade

Fenne L. Komdeur

10 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fenne L. Komdeur Netherlands 6 426 424 55 55 44 11 562
Hagma H. Workel Netherlands 8 354 0.8× 358 0.8× 46 0.8× 58 1.1× 41 0.9× 10 473
Iris Halfpenny United Kingdom 9 273 0.6× 66 0.2× 59 1.1× 75 1.4× 17 0.4× 11 424
Eriko Yokoi Japan 16 258 0.6× 329 0.8× 104 1.9× 102 1.9× 172 3.9× 24 588
P. Dominick Sanders United States 8 169 0.4× 251 0.6× 78 1.4× 9 0.2× 15 0.3× 11 383
Ana Montes United Kingdom 11 73 0.2× 86 0.2× 56 1.0× 72 1.3× 20 0.5× 31 236
Alexander S. Dudnichenko Ukraine 4 147 0.3× 227 0.5× 89 1.6× 89 1.6× 5 0.1× 5 431
Milja Kaare Finland 9 60 0.1× 148 0.3× 149 2.7× 17 0.3× 44 1.0× 14 335
Lucia Musacchio Italy 15 93 0.2× 283 0.7× 151 2.7× 203 3.7× 170 3.9× 46 551
James Favaloro Australia 9 260 0.6× 203 0.5× 118 2.1× 10 0.2× 11 0.3× 18 500
Shihong Yang Australia 10 254 0.6× 180 0.4× 105 1.9× 11 0.2× 11 0.3× 21 403

Countries citing papers authored by Fenne L. Komdeur

Since Specialization
Citations

This map shows the geographic impact of Fenne L. Komdeur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenne L. Komdeur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenne L. Komdeur more than expected).

Fields of papers citing papers by Fenne L. Komdeur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenne L. Komdeur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenne L. Komdeur. The network helps show where Fenne L. Komdeur may publish in the future.

Co-authorship network of co-authors of Fenne L. Komdeur

This figure shows the co-authorship network connecting the top 25 collaborators of Fenne L. Komdeur. A scholar is included among the top collaborators of Fenne L. Komdeur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenne L. Komdeur. Fenne L. Komdeur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hollema, Harry, Marise M. Wagner, Helena C. van Doorn, et al.. (2024). High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers. JNCI Journal of the National Cancer Institute. 117(4). 719–727. 2 indexed citations
2.
Schaapveld, Michael, Marjoleine F. Broekema, Margriet Collée, et al.. (2024). Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families. Genetics in Medicine. 26(9). 101171–101171. 2 indexed citations
3.
Ausems, Margreet G.E.M., Inge M. van Oort, C. Marleen Kets, et al.. (2024). Men with metastatic prostate cancer carrying a pathogenic germline variant in breast cancer genes: disclosure of genetic test results to relatives. Familial Cancer. 23(2). 165–175.
4.
Crabben, Saskia N. van der, Fenne L. Komdeur, Esther J. Nossent, et al.. (2021). Genetic Diagnosis in Sudden Cardiac Death: The Crucial Role of Multidisciplinary Care. SHILAP Revista de lepidopterología. 11(2). 68–72. 1 indexed citations
5.
Paijens, Sterre T., Maartje C.A. Wouters, Fenne L. Komdeur, et al.. (2020). Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome. OncoImmunology. 9(1). 1760705–1760705. 26 indexed citations
6.
Workel, Hagma H., Joyce M. Lubbers, Roland Arnold, et al.. (2019). A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer. Cancer Immunology Research. 7(5). 784–796. 167 indexed citations
7.
Komdeur, Fenne L., Thalina M. Prins, Stephanie van de Wall, et al.. (2017). CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer. OncoImmunology. 6(9). e1338230–e1338230. 129 indexed citations
8.
Workel, Hagma H., Fenne L. Komdeur, Maartje C.A. Wouters, et al.. (2016). CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma. European Journal of Cancer. 60. 1–11. 113 indexed citations
9.
Wouters, Maartje C.A., Fenne L. Komdeur, Marco de Bruyn, & Hans W. Nijman. (2016). Size matters: Survival benefit conferred by intratumoral T cells is dependent on surgical outcome, treatment sequence and T cell differentiation. OncoImmunology. 5(5). e1122863–e1122863. 2 indexed citations
10.
Komdeur, Fenne L., Maartje C.A. Wouters, Hagma H. Workel, et al.. (2016). CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy. Oncotarget. 7(46). 75130–75144. 64 indexed citations
11.
Wouters, Maartje C.A., Fenne L. Komdeur, Hagma H. Workel, et al.. (2015). Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer. Clinical Cancer Research. 22(3). 714–724. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026